Sign in

CIK 0001561921

  • Non-accelerated filer
  • Smaller reporting company

TELA Bio, Inc.

Sign in to watch
Ticker
TELA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455320061
Phone
+1 484-320-2930
Business address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
Open-market buys, last 90 days
$167,238
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$167,238. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Capper Joseph H +$167K Director 2 filings
Date Insider Transaction Shares Price Value Owned after
2019-11-13 Friedman Ashley Director Conversion · Series B Preferred Stock −1,479,951 0
2019-11-13 Friedman Ashley Director Conversion · Series B Preferred Stock −7,051,009 0
2019-11-13 Friedman Ashley Director Conversion · Warrant (right to buy) −31,168 0
2019-11-13 Friedman Ashley Director Conversion · Warrant (right to buy) +31,168 31,168
2019-11-13 Friedman Ashley Director Conversion · Warrant (right to buy) −148,499 0
2019-11-13 Friedman Ashley Director Conversion · Warrant (right to buy) +148,499 148,499
2019-11-13 Oliva Adele C Director Conversion +345,489 1,234,153
2019-11-13 Oliva Adele C Director Conversion +516,947 1,751,100
2019-11-13 Oliva Adele C Director Conversion · Series A Preferred Stock −8,530,145 0
2019-11-13 Oliva Adele C Director Conversion · Series B Preferred Stock −12,763,434 0
2019-11-13 Oliva Adele C Director Conversion · Warrant (right to buy) −446,813 0
2019-11-13 Oliva Adele C Director Conversion · Warrant (right to buy) +446,813 446,813
2019-11-13 ORBIMED ADVISORS LLC 10% owner Conversion +481,095 2,049,722
2019-11-13 ORBIMED ADVISORS LLC 10% owner Conversion +977,820 3,027,542
2019-11-13 ORBIMED ADVISORS LLC 10% owner Conversion · Series A Preferred Stock −11,878,249 0
2019-11-13 ORBIMED ADVISORS LLC 10% owner Conversion · Series B Preferred Stock −24,142,419 0
2019-11-13 ORBIMED ADVISORS LLC 10% owner Conversion · Warrant (right to buy) −758,623 0
2019-11-13 ORBIMED ADVISORS LLC 10% owner Conversion · Warrant (right to buy) +758,623 758,623
2019-11-08 Quaker BioVentures II LP 10% owner Purchase +153,846 $13.00 $2.0M 888,664
2019-11-08 Zuga Matt Director Purchase +10,220 $13.00 $133K 12,675

Page 28 of 29 · 565 trades